Share Email Print

Proceedings Paper

State-of-the-art clinical multimodal multi photon / CARS / FLIM tomography of human skin (Conference Presentation)
Author(s): Karsten König
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Recent translation of multiphoton microscopy to clinical practice raises the possibility of high-resolution in-vivo histology of skin. This is of special interest for cancer diagnostics, because early stages of basal cell carcinomas (BCCs) and malignant melanomas (MM) can be imaged. The novel label-free non-invasive process, called multiphoton tomography (MPT), would reduce the time from consultation to treatment. MPT is a nonlinear laser scanning microscopy technique that features high three-dimensional resolution and label-free molecular contrast. Several endogenous tissue components can be visualized, including collagen (through second-harmonic generation), NAD(P)H, FAD, keratin, melanin, porphyrins, and elastin fibers (through two-photon excited fluorescence). Furthermore, fluorescence lifetime imaging (FLIM) can be employed to detect inflammation sites in patients suffering from dermatitis and chronic wounds. The add-on module CARS (Coherent Anti-Stokes Raman Spectroscopy) provides information on the lipid and water distribution. Multimodal MPT is performed in high-tech hospitals in Europe (e.g. Charité/Germany), China, Russia (e.g. Medical Academy, Nizhny Novgorod), Australia (e.g. Princess Alexandra Hospital, Brisbane) and United States (e.g. Beckman Laser Institute and Medical Clinic UCI, Irvine, and University of Illinois at Urbana-Champaign).

Paper Details

Date Published: 14 March 2018
Proc. SPIE 10467, Photonics in Dermatology and Plastic Surgery 2018, 104670L (14 March 2018); doi: 10.1117/12.2287383
Show Author Affiliations
Karsten König, JenLab GmbH (Germany)

Published in SPIE Proceedings Vol. 10467:
Photonics in Dermatology and Plastic Surgery 2018
Bernard Choi; Haishan Zeng, Editor(s)

© SPIE. Terms of Use
Back to Top